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Abstract
Background: The Health Department of the Regional Government of Catalonia, Spain, issued a quality plan for
substance abuse centers. The objective of this paper is to evaluate the impact of a multidimensional quality
improvement initiative in the field of substance abuse care and to discuss potentials and limitations for further
quality improvement.
Methods: The study uses an uncontrolled, sector-wide pre-post design. All centers providing services for persons
with substance abuse issues in the Autonomous Community of Catalonia participated in this assessment. Measures
of compliance were developed based on indicators reported in the literature and by broad stakeholder
involvement. We compared pre-post differences in dimension-specific and overall compliance-scores using one-
way ANOVA for repeated measures and the Friedman statistic. We described the spread of the data using the
inter-quartile range and the Fligner-Killen statistic. Finally, we adjusted compliance scores for location and size
using linear and logistic regression models.
Results: We performed a baseline and follow up assessment in 22 centers for substance abuse care and observed
substantial and statistically significant improvements for overall compliance (pre: 60.9%; post: 79.1%) and for
compliance in the dimensions ‘care pathway’ (pre: 66.5%; post: 83.5%) and ‘organization and management’ (pre:
50.5%; post: 77.2%). We observed improvements in the dimension ‘environment and infrastructure’ (pre: 81.8%;
post: 95.5%) and in the dimension ‘relations and user rights’ (pre: 66.5%; post: 72.5%); however, these were not
statistically significant. The regression analysis suggests that improvements in compliance are positively influenced
by being located in the Barcelona region in case of the dimension ‘relations and user rights’.
Conclusion: The positive results of this quality improvement initiative are possibly associated with the successful
involvement of stakeholders, the consciously constructed feedback reports on individual and sector-wide
performance and the support of evidence-based guidance wherever possible. Further research should address how
contextual issues shape the uptake and effectiveness of quality improvement actions and how such quality
improvements can be sustained.
Background
Over the last decade a multitude of performance assess-
ment and quality improvement activities have targeted
the health care sector. In addition to regional and
national initiatives, efforts led by the World Health Orga-
nization or the Organization for Economic Development
and Cooperation aim at assessing and evaluating health
care and health systems in an international comparative
perspective [1-3]. Indeed, industrial approaches to quality
improvement and performance assessment have been
applied to health care since the 1960s, spearheaded by
the works of Avedis Donabedian [4,5]. While most atten-
tion has initially focused on the hospital setting and pri-
mary care, more and more attention is being been paid
on other health and social care facilities in general, and
mental health [6-8] and substance-abuse centers in parti-
cular [9-12].
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Relevant initiatives to improve the quality in this sec-
tor are for example the treatment protocols and techni-
cal assistance publications (including models of good
practice) that are being prepared by the US Center for
Substance Addiction Treatment [13]; the Accreditation
Manual for Behavioral Care issued by the Joint Commis-
sion [14], or the epidemiological studies and reports that
are linked to evaluation and improvement efforts pub-
lished by the European Monitoring Center for Drugs
and Drug Addiction [15]. Moreover, traditional quality
management models, such as the European Foundation
for Quality Management (EFQM) model, have been
applied to substance abuse centers [16]. In Spain, too,
various Autonomous Communities have launched activ-
ities to improve the quality of substance-abuse centers,
for example the evaluation based on the Common
Assessment Framework carried out by the Government
of Cantabria, the assessment of compliance of substance
abuse centers with a set of standards conducted by the
Institute for Addiction Research in Madrid and the
quality plan and external evaluation system deployed by
the Catalonian Government to improve substance abuse
services [17]. We described the conceptual basis of the
latter system in a previous article [18].
In the following, we provide a more in-depth applica-
tion of the evaluation framework widely used in health
care to centers that provide ambulatory substance abuse
services for people with drug dependencies. In order to
address the quality issues of concern in these centers
(adherence to treatment, continuity of care) and the
multiple factors causing them, quality improvement
efforts need to adapt a multi-professional approach that
takes into consideration social, clinical, psychological
factors as well as the user’s views and satisfaction. The
objective of this paper is thus to evaluate the impact of
a multidimensional quality improvement initiative in the
field of substance abuse care in the Autonomous Region
of Catalonia, Spain, and to discuss potentials and limita-
tions for further quality improvement.
Methods
Setting
This study was conducted in the context of the quality
plan issued by the Health Department of the Autono-
mous Government of Catalonia. The plan states the
need for quality improvement efforts directed at centers
for substance-abuse service and follow up (CAS), with
particular attention on existence of assessments of qual-
ity as perceived by the users of the centers. CAS provide
services by multi-professional teams including physi-
cians, psychologists, social works and nurses that review
on a case by case basis the needs and treatment forms
for each patient and assess further health and social
care needs, such as the use of therapeutic communities
or hospitalization in an detoxication unit. These centers
can offer different treatment options such as methadone
treatment or treatment with narcotic antagonists and a
like. In addition, some CAS are linked to small periph-
eral centers that facilitate for example medication dis-
pensing. Performance of these small units is not
included in the analysis presented here.
Measures and data sources
Considering that developing performance measures can
be very resource demanding, we developed the measures
for external evaluation based on reviews of the litera-
ture, consensus methods including subject experts and
involving a broad range of stakeholders. The key pre-
mise in this process is to address issues that are of con-
cern of practicing health and social care professionals,
to include the latest scientific evidence and expert
knowledge in the definition of indicators and to ensure
practicality and timeliness of the work. The measure-
ment development would first draw on previously
reported and validated survey measures, data collection
instruments and indicators. Multi-disciplinary stake-
holder groups then meet five to seven times to discuss
how the measures reflect the main problems in the sec-
tor, identify objectives that can be met within three
years, consent on the key measurement area and review,
prioritize and technically define the measures. The
development and psychometric testing of new indicators
that require complex surveys or clinical scores is not the
intention and is beyond the scope of our work. Indica-
tors are defined using a standardized template. For each
indicator, standards are set based on a review of the lit-
erature and consensus in the group. Standards are set to
encourage improvement as considered to be achievable
by stakeholders within the next 2 or 3 years, after which
they will be measured again and a new set is developed.
Indicators for which a majority of centers are already
performing very well will be discarded. The process of
measure development is described in more detail else-
where [18,19].
Data sources used for the external evaluation depended
on the criteria and dimension of care assessed. This
includes revisions of clinical records for care processes
and follow-up indicators, direct observation for structural
indicators, harm reduction program and assessment of
systems for user evaluation, and revision of specific docu-
ments such as program descriptions, protocols and min-
utes for the remaining indicators. For standardization
and quality assurance purposes, all data are recorded in a
specifically developed program in MS ACCESS.
For indicators based on user records we took a random
sample of 100 records based on the user lists provided by
the centers. All patients are included at the sampling
stage. In the instance of small centers not reaching this
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number we assessed all cases. Data extraction is based on
an algorithm taking into account the type of indicator,
non-applicability of measurable elements and level of
compliance. These measures are then aggregated at indi-
cator level (an indicator is typically based on around four
measurable elements) and in a subsequent step at dimen-
sion level. The original data format specifies for each cen-
ter, indicator and assessment period (pre-post) whether
the predetermined standards were met. Based on the
indicator-specific dichotomous compliance scores we cal-
culated center-level compliance scores for each perfor-
mance dimension. The resulting scores can be expressed
as follows:
• Overall compliance: for each centre, the total
number of indicators that are in compliance divided
by the total number of indicators evaluated (where
“Compliant/NotCompliant” is a dichotomous vari-
able (1 = compliant, 0 = not compliant) and m is
the number of indicators evaluated.
OverallCompliance
Compliant NotCompliant
m
i
m
= ×=
∑ /
,1 100
• For each of the 4 dimensions: for each centre, the
total number of indicators related to the respective
dimension divided by the total number of indicators
evaluated for the same dimension (where “Compliant/
NotCompliant” is a dichotomous variable (1 = com-
pliant, 0 = not compliant) and “m Indicadors Evalu-
ated in the dimension” is the number of indicators
evaluated):
DimensionA
IndicatorEvaluatedDimensionCompliant NotComplia
=
/ nt
i
m
mIndicatorsEvaluatedDimension
=
∑
×1 100
These resulting scores are continuous (except for the
dimension ‘environment and infrastructure’ as this is com-
posed of only one indicator) and allow for the comparison
of pre-post compliance scores. While the aggregate mea-
sures account for applicability of the item assessed and for
missing data, we did not weight individual indicators. For
example, the correct registration of drug prescriptions is
not assigned more weight than, say, providing vaccination
against Hepatitis B to users at risk. The rationale for this is
that given the different views in the multi-disciplinary
measure development stakeholder group (involving users)
we could not consent on criteria that would justify weight-
ing of indicators.
External evaluation and quality improvement
Centers were informed before the visit about the evalua-
tion schedule and the documents required during the
evaluation. Baseline evaluation was carried out in 2001
and follow up evaluation was performed in 2004. Between
the two evaluations, centers received specific performance
reports including targeted recommendations for quality
improvement. At the same time a sector-wide report was
published including the baseline assessment (without iden-
tifying individual providers) and recommendations for sec-
tor-wide improvements. Evaluators received a 40 hour
training for the assessment exercise including a presenta-
tion of the indicators, data sources, the assessment instru-
ment and overall methodology. A pilot test was carried
out to test the assessment material and the reliability of
the assessment by different evaluators. The assessment of
inter-rater reliability itself is outsourced to another scienti-
fic institute (the Ibero-American Cochrane Collaboration,
Barcelona) to limit any biases results from personal
acquaintance with the evaluators.
Subsequent to the evaluation, and in order to facilitate
quality improvement initiatives in the participating cen-
ters, each center received an individualized quality
improvement report. This report indicates the results of
the assessment, offers concrete proposals for quality
improvement and provides anonymized comparative
data on other center’s performance. In addition, a sector
wide report is prepared to address quality issues beyond
individual center’s research and is discussed at sector
level, involving health policy and other stakeholders.
Based on the later report, quality improvement actions
are consented at sector level.
Data analysis
We computed indicator-, dimension-specific and overall
compliance scores based on the calculation of compli-
ance with measurable elements. Using these scores we
present overall and dimension-specific results for base-
line and follow up evaluation with descriptive statistics of
tendency and variation. We performed one-way analysis
of repeated measures (ANOVA) and the Friedman statis-
tic to assess the level of statistical significance for differ-
ences between baseline and follow-up evaluation. To test
whether sector wide changes in performance are asso-
ciated with reduced spread in individual center’s perfor-
mance we assessed changes in inter-quartile range and
the Fligner-Killeen statistic for the performance dimen-
sions between baseline and follow-up assessment. Finally,
in order to control for the effect of the structural center-
characteristics ‘location’ and ‘size’, we entered these vari-
ables into multiple linear and logistic regression models.
Data analysis was performed using SPSS 17 and the R
statistical software package (version 2.10.1).
Results
We assessed and followed up all 22 Centers for Attention
and Follow Up participating in the quality plan and
Hilarion et al. Substance Abuse Treatment, Prevention, and Policy 2010, 5:26
http://www.substanceabusepolicy.com/content/5/1/26
Page 3 of 11
providing services to persons addicted to drugs and other
substances in the Autonomous Community of Catalonia,
Spain (reflecting the whole sector). In Table 1, we pro-
vide an overview on the distribution of centers by geo-
graphic territory as well as descriptive statistics on the
number and characteristics of their users (Table 1).
The majority of centers for attention and follow up,
corresponding to the highest concentration of need and
demand, are based in the Barcelona region. The stan-
dard deviations for the reported means on active users
reflect that the size of the centers in terms of users (but
also in terms of professionals and infrastructures) differs
widely. It took an average one-person day to perform
the evaluation in each center.
All Centers for Attention and Follow Up were evalu-
ated twice using consensus indicators developed jointly
with the stakeholders. These indicators were designed to
be applicable to all centers. Table 2 gives an overview
on the indicators, their relation to the multidimensional
evaluation framework and their distribution across
dimensions, themes, indicators, and measurable ele-
ments. Overall, the evaluation framework includes 4
dimensions, 20 themes, 35 indicators and 169 measur-
able elements (Table 2).
The number of measurable elements for each indicator
was determined based on the indications from stake-
holders regarding key aspects to be assessed. The median
number of measurable elements per indicator is 4, but
some indicators are assessed by only one measurable ele-
ment while others are assessed by up to 16. Evaluators
assessing the indicators are specifically trained in data
collection and use standardized algorithms and data
entry sheets for data collection.
The number of cases that forms the basis of the calcu-
lation of the indicators differs substantially as some indi-
cators are based on the random review of a sample 100
user records, others are based on a full review of user
records (in case the number of users for this indicator is
<100 at center level) and again others are based on
assessment at center level, for example, the external eva-
luators’ assessment of the availability of certain organi-
zational procedures.
For some indicators we observed negative changes in
compliance ratings (indicators 2, 7, 16, 17, 19, 20, 25).
In case of indicators 2 and 25, these negative changes
can be explained by a substantial increase in demand
that coincided with the evaluation period and centers
were not prepared for this increase. For indicators 16,
17, 19 and 20 other institutions or third parties were
established during the evaluation period and took over
some responsibilities that were initially held at the level
of the center (such as the complaint handling system).
Finally, indicators 7 on the follow up of users proved to
be very difficult to achieve due to the reluctance of
those users already on methadone to establish contact
with the CAS.
After the baseline evaluation using these indicators, a
bundle of quality improvement actions were initiated
both at the level of the sector and at the level of indivi-
dual centers. Key to these quality improvement actions
were the performance reports provided to each center
which depict the center’s performance in relation to the
sectors performance. Thus, each center could identify
targeted quality improvement actions in areas where the
center’s performance was below standard. In addition to
these center-specific performance reports, a sector-wide
performance report was published focusing on quality
improvement actions that require consorted actions or
changes in the normative framework. The following
table gives an example of a performance report for one
of the indicators (Table 3).
The performance report provides information on com-
parative benchmarking for each indicator and pinpoints at
measurable elements that were evaluated particularly low.
Target audience of the report is the center’s management
and involved professionals. It should be noted that the
performance report sent to each center includes such a
detailed assessment for each of the 35 indicators, accom-
panied by graphical illustrations of relative performance.
After the publication of the performance reports, local
quality improvement actions were established, imple-
mented and evaluated in the follow-up evaluation. For
example, centers participated in the public presentation
of the results and in the elaboration of the document on
good practices. The good-practice document provides
for all indicators that were evaluated as below target
performance detailed rationales, improvement steps and
reference documents in order to facilitate the use of this
information for quality improvement activities. Specific
quality improvement actions initiated on the basis of the
Table 1 Participating centers: distribution and users
Characteristic
Total number of centers (% of the sector)* 22 (100%)
Centers by geographic territory (%)
Barcelona 16 (72.7%)
Girona 1 (4.5%)
Lleida 2 (9.1%)
Tarragona/Delta de l’Ebro 3 (13.6%)
Number of active users
Total users 13701
Mean/median users per center 622.8; 540.0
Standard deviation 399.4
Users on methadone 4006
Mean/median users per center 182.1; 160.0
Standard deviation 127.4
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Table 2 Evaluation of individual center's performance: domains, themes, indicator and measurable element
Domain Theme Indicator N (cases
revised)*
Standard Compliance
At
baseline
At
follow
up
Change
Care
pathway
Process of
admittance
1. Ensure follow up visits after user contacts and
hospitalizations.
2476 75% 100.0% 100.0% 0.0%
Process of care 2. Offer an individualized treatment plan in appropriate
timeframe.
1312 90% 100.0% 95.5% -4.5%
3. Offer vaccination against hepatitis B to all users at risk. 757 90% 40.9% 63.6% 55.5%
4. Provide access to counseling services to HIV positive
users.
703 85% 4.5% 57.1% 1168.9%
5. Provide a list of treatments and services, including a
description of the nature of the intervention.
184 100% 45.5% 86.4% 89.9%
Pharmacological
treatment
6. Register patients drug prescriptions properly. 1223 100% 72.7% 90.9% 25.0%
Follow up care 7. Follow up users in the methadone maintenance
programme at least every 6 months.
1119 90% 90.9% 77.3% -15.0%
8. Support the user in adhering to the care pathway. 14256 85% 65.0% 86.4% 32.9%
9. Actively follow up patients that do not attend the
dispensing of methadone.
542 90% 50.0% 50.0% 0.0%
Prevention 10. Promote and participate in prevention activities (on
own initiative, in coordination with community agencies
or by indication of agencies).
64 100% 95.5% 95.5% 0.0%
Harm reduction
program
11. Have standardized guidelines for the prevention of risk
behaviors associated with substance use and sexual
behavior.
152 100% 63.6% 90.9% 42.9%
12. Provide injection equipment (syringes) to intravenous
drug users.
52 100% 59.1% 100.0% 69.2%
13. Have programs aimed at (potential) users not yet in
contact with the center.
53 100% 86.4% 90.9% 5.2%
Relations and
user rights
Confidentiality 14. Ensure confidentiality of all user-related data. 83 100% 40.9% 72.7% 77.7%
Information 15. Ensure that users have all the necessary information to
take an informed decision regarding all health-related
actions.
1150 100% 4.5% 22.7% 404.4%
User satisfaction 16. Demonstrate a system of dealing with complaints
(ensuring feedback within two weeks).
59 80% 80.0% 76.9% -3.9%
17. Assess the satisfaction of users with the services
received.
100 100% 36.4% 36.4% 0.0%
Family
involvement
18. Have an action plan with families, encompassing
monitoring and periodic contacts, every six months.
683 80% 90.9% 86.4% -4.9%
Community
involvement
19. Promote the reintegration of the user in the
community.
528 80% 100.0% 95.5% -4.5%
20. Engage in efforts to improve community acceptance. 57 100% 100.0% 95.5% -4.5%
21. Conduct activities to improve social acceptance of care
in collaboration with associations, councils, regional
councils, etc.
56 90% 86.4% 95.5% 10.5%
Environment
and
infrastructure
Appropriateness
of the facilities
22. Designate a space reserved for the intake and
dispensing of methadone.
53 100% 81.8% 95.5% 16.7%
Organization
and waiting
times
23. Provide written information to the population at risk
about the services, including information on treatment,
hours, place of care.
124 100% 40.9% 95.5% 133.5%
24. Anticipate the provision of services to patients outside
opening hours.
61 100% 63.6% 81.8% 28.6%
Hilarion et al. Substance Abuse Treatment, Prevention, and Policy 2010, 5:26
http://www.substanceabusepolicy.com/content/5/1/26
Page 5 of 11
good-practice document may for example be the admin-
istration of a user satisfaction survey, the implementa-
tion of a new protocol or the introduction of an
organizational policy towards collaboration with other
providers of substance abuse services. Based on indivi-
dual performance reports, some centers also requested
specific advice from the research coordination team on
how to improve the quality of services.
Major improvements between baseline and follow up
evaluation can be observed for most of the 20 themes eval-
uated (Figure 1, Results at the level of individual indicators
are reported in Table 2). Exceptions can be observed in
the four areas: adequate space, prevention, community
relations and overall satisfaction. In the remaining 16
areas, major improvements were made at sector level.
In order to assess statistical significance for the differ-
ences observed, we carried out comparisons between
baseline and follow up evaluation and performed a one-
way ANOVA analysis for repeated measures and the
Friedman statistic to assess the improvements in overall
and dimension-specific performance (Table 4).
Global improvement in mean compliance between base-
line assessment and follow up evaluation is substantial
(29.9%; 95% Confidence Interval (CI): 22.4-37.3; ANOVA,
F1, 21 = 47.4). Since we were interested not only in the
improvements of individual centres but also in the
improvement of the sector as a whole, we assessed
whether improvements observed are also accompanied by
diminished variance between centers. The assessments
using the inter-quartile range (IQR) yielded reductions for
the dimensions ‘overall compliance’ (IQRpre: 0.179; IQR-
post: 0.142) and ‘care pathway’ (IQRpre: 0.18, IQRpost:
0.14), but not for the dimensions ‘relations and user rights’
(IQRpre: 0.18, IQRpost: 0.30) and ‘organization and man-
agement’ (IQRpre: 0.16, IQRpost: 0.24). Given the dichoto-
mous nature of the indicator for the dimension
environment and infrastructure, we could not compute
this statistic for this dimension.
In order to formally analyze the reduction in variance
between pre-post assessments, we performed the Fligner-
Killen test for changes in overall and dimension-specific
compliance which yielded the following p-values: ‘overall
compliance’ = 0.418 (Fligner-Killeen Test = 0.67; df = 1),
‘care pathway’ = 0.043 (Fligner-Killeen Test = 4.10; df = 1),
‘relations and users rights’ = 0.165 (Fligner-Killeen Test =
1.93; df = 1) and ‘organization and management’ = 0.963
(Fligner-Killeen Test = 0.002; df = 1). According the
results of the Fligner-Killen test, the reduction in variance
between pre and post assessment is only significant for the
dimension ‘care pathway’.
Table 2 Evaluation of individual center's performance: domains, themes, indicator and measurable element (Continued)
25. Initiate diagnosis and therapy in a period no longer
than 2 weeks of initial visit.
1325 80% 88.2% 76.2% -13.6%
Documentation
systems and
registries
26. Document the clinical history for all users actively
attended in center.
1266 100% 59.1% 86.4% 46.2%
27. Make accessible the clinical documentation generated
during the visits to all members of the multi-professional
team.
1321 95% 95.5% 100.0% 4.7%
Organization
and
management
Multi-
professionalcare
28. Assess all patients in the care at least once by the
professionals who comprise the multi-professional team.
1197 75% 31.8% 63.6% 100.0%
Protocols 29. Demonstrate protocols for the triage of users with
organic pathologies.
159 100% 36.4% 90.9% 149.7%
30. Demonstrate protocols for the triage of users with
psychopathologies.
81 100% 45.5% 72.7% 59.8%
31. Demonstrate protocols for the triage of pregnant
woman users.
101 100% 40.9% 90.9% 122.2%
Continuing
education
32. Professional should participate in continuing education
activities.
375 80% 45.5% 63.6% 39.8%
Professionals’
opinion
33. Carry out regular surveys on the opinion of
professionals.
57 100% 18.2% 40.9% 124.7%
Coordination
with other levels
of care
34. Establish stable relationships and coordination with
affiliated social services and legal agencies.
170 100% 45.5% 68.2% 49.9%
35. Coordinate work plan with the health care area
administration, mental health centers and referral hospitals.
219 100% 54.5% 72.7% 33.4%
* the differences in the denominators between indicators is due to the level at which the indicators is selected: records (depending on type of user) at user level
or organizational policies at center level.
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In terms of dimension-specific results, improvements
ranging from 9.0% to 52.9% can be observed. Improve-
ments were statistically significant in the dimensions ‘care
pathway’ (pre: 66.5%, post: 83.5%; 95% CI for improvement
in compliance: 15.0-36.1, Chi21 = 9.8) and ‘organization
and management’ (pre: 50.5%, post: 77.2%; 95% CI for
improvement in compliance: 37.8-67.9, Chi21 = 11.64). We
observed improvements for the dimension environment
and infrastructure’ (pre: 81.8%; post: 95.5%) and the
dimension ‘relations and user rights’ (pre: 66.5%; post:
72.5%), however, these improvements were not statistically
significant.
In a final step, and in order to assess whether improve-
ments in compliance are influenced by the location of
the center or its size, we entered the following variables
into a regression model: change in compliance between
baseline and follow up evaluation, location and size. To
this end we created dummy variables for location of the
center (Barcelona vs. elsewhere) and for its size (small,
medium, large; based on the distribution of the mean
number of users per centers in terciles). Table 5 reports
the improvement in overall and dimension-specific
compliance by location and size of the center using mul-
tiple linear and logistic regression models. According to
the model for ‘overall compliance’ (R2 = 0.19, F3, 18 =
1.42), smaller centers reach higher improvements (B-
value for ‘big’ compared to ‘small’ = -0.39) and centers in
Barcelona improve more than others (B-value for ‘Barce-
lona’ = 0.65), however, these factors are not significant in
the model (p-value = 0.27). Thus, it seems that the
improvements presented in Table 4 are not confounded
by these factors and centers appear to improve on the
whole, irrespective of location and size.
In the linear regression models for the dimensions
‘care pathway’ and ‘organization and management’ the
factors location and size are not significant. However,
the factor ‘location = Barcelona’ is significant in the
model for the dimension ‘relations and user rights’ (p =
0.03, F3, 18 = 3.80, R
2 = 0.39). For the dimension ‘envir-
onment and infrastructure’ we fitted a logistic regression
model, given the dichotomous nature of this dimension
based on only one indicator. The odds-ratios and corre-
sponding 95% confidence intervals do not suggest an
influence of size and location on probability to improve.
Table 3 Example of quality improvement report for one indicator
Criterion number 34
Domain Organization and management
Theme Coordination with other levels of care
Indicator Establish stable relationships and coordination with affiliated social services and agencies competent in legal
matters pertaining to the Department of Justice.
Rationale The range of legal and social problems associated with drug use requires a suitable level co-operation and
coordination with the network of social services and agencies in legal matters in the Department of Justice.
Measurable elements This will be assessed in terms of:
- stable mechanisms for interaction and coordination
- an established work plan containing a schedule of meetings
- communication channels
- a registry system
- specific protocols.
Standard 100,0% (all measurable elements should be in full compliance with)
Sector performance (2001) 68.2% (the average compliance with the criterion in the overall center)
Your performance (2001) 47.3% (the compliance with the criterion in your center)
Results The average performance of this indicator in the sector (68.2%) is below the established standard. Of all centers in
the sector, none was completely non-compliant and 15 of the 22 centers were fully compliant.
Targets for quality
improvement action
Compliance with measurable elements was as follows:
- Evidence of some coordination with other levels of care: 93,5%
- Calendar of Meetings: 29,5%
- Stable communication channels: 15,9%
- Registration system: 13,6%
- Consensus protocols of action: 40,9%
- Referral protocols and tracking: 43,2%
The main reason for non-performance of this indicator has been the lack of systematic work with the department
of justice followed by lack of collaboration with other social services. Moreover, compliance with protocols for
intervention and monitoring of cases is low. The areas indicated above should be the target of further
improvement work.
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Discussion
We assessed and facilitated quality improvement activ-
ities in 22 Centers for Attention and Follow Up in the
Autonomous Community of Catalonia, Spain. Using
consensus indicators developed with the involvement of
key stakeholders we carried out a baseline assessment,
prepared targeted performance reports and performed a
follow-up assessment. Overall, we observed substantial
and statistically significant improvements in the whole
sector. The results of the regression analysis in general
do not suggest that centers in Barcelona and those
being larger differ substantially in their compliance
Figure 1 Compliance at theme-level at baseline and follow up evaluation.
Table 4 Global results - baseline and follow up assessment
Domain Mean compliance at
baseline assessment
Mean compliance at
follow up evaluation
Improvement in compliance (%;
95% confidence interval)
P-value for
difference in
compliance*
Statistic
Overall compliance1 60.9% 79.1% 29.9% (22.4%; 37.3%) < 0.001 F1,12 =
47.40
By dimension
Care pathway2 66.5% 83.5% 25.6% (15.0%; 36.1%) 0.002 Chi21=
9.8
Relations and
user rights1
66.5% 72.5% 9.0% (-5.9%; 23.9%) 0.124 F1,21=
2.57
Organization
and
management2
50.5% 77.2% 52.9% (37.8%; 67.9%) < 0.001 Chi21=
11.64
Environment
and
infrastructure3
81.8% 95.5% 13.63% (-0.7%; 28.0%)4 0.16 (0.002)5 T Wald
= -2.97
1ANOVA ONE-WAY for repeated measures.
2 Friedman Test.
3 Logistic regression with dependent variable ‘improvement in compliance’.
4 Hospitals that improved: % (95% CI).
5 Odds-ratio (hospitals improved/hospitals did not improve: the probability to improve is significantly lower than 1 (0.136) at p-value 0.002.
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Table 5 Improvement by location and size for overall and dimension-specific compliance
Domain B SE B b (p-value) Notes Goodness of fit
Overall Compliance1 -2.19 0.33 (< 0.001) R2 = 0.19 F3,18 = 1.42
p-value = 0.27
- Constant2
- Size — — —
Small -0.33 0.38 -0.21 (0.393)
Medium -0.39 0.37 -0.25 (0.314)
Big
- Location — — —
Elsewhere 0.65 0.35 0.40 (0.079)
Barcelona
Care pathway1 F3,18 = 0.27
p-value = 0.84
- Constant 0.13 0.09 (0.195) R2 = 0.04
- Size
Small — — —
Medium 0.01 0.11 0.02 (0.934)
Big -0.04 0.11 -0.10 (0.692)
- Location
Elsewhere — — —
Barcelona 0.07 0.10 0.17 (0.489)
Relations and user right1 F3,18 = 3.80
p-value = 0.03
- Constant -0.12 0.06 (0.070)
- Size R2 = 0.39
Small — — —
Medium 0.07 0.07 0.23 (0.289)
Big 0.04 0.07 0.12 (0.585)
- Location
Elsewhere — — —
Barcelona 0.19 0.06 0.54 (0.009)
Organization and management1 F3,18 = 1.76
p-value = 0.19
- Constant 0.30 0.10 (0.011) R2 = 0.23
- Size
Small — — —
Medium -0.24 0.12 -0.73 (0.055)
Big -0.17 0.12 -0.50 (0.168)
- Location
Elsewhere — — —
Barcelona 0.14 0.11 0.41 (0.211)
Environment and infrastructure3 Residual Deviance on 18 degrees of freedom = 14.71
p-value = 0.68
- Constant -0.96 1.19 0.38 (-4.00;1.21)4 0.4215
- Size
Small
Medium -0.69 1.40 0.52 (-3.92;2.08)4 0.6485
Big -18.45 4060.75 ~0 (inf;inf) 0.9965
- Location
Elsewere — — — —
Barcelona -0.23 1.45 0.79 (-3.04;3.12)4 0.8745
1 Multiple linear regression.
2 Box-cox transformation (log).
3Multiple logistic regression.
4 Odds-ratio (95% CI).
5 p-value.
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scores. An exception is the dimension ‘relations and
user rights’ for which the regression analysis suggest a
positive effect of a center being located in Barcelona.
We interpret the improvements as follows: first, the
broad involvement of professionals in the design of con-
sensus indicators and the participation of a large number
of centers from the whole sector creates common sense
and motivates improvement. Moreover, it allows setting
challenging but realistic targets. Secondly, the combina-
tion of targeted feedback - to individual centers on the
one hand and to the whole sector on the other - allows
addressing confidentially those providers with low perfor-
mance and, in collaboration with all stakeholders, bring-
ing about change in the whole sector for those issues that
require changes at the regulatory level. Both feedback
mechanisms are consciously constructed, elaborated in
collaboration with the participants and are supported by
evidence-based guidance wherever possible. Moreover,
center’s feedback reports are addressed to the center’s
Chief Executive rather than individual professionals, and
prepared in a way to support management in implement-
ing change. Finally, the involvement of the whole sector
and a wide range of stakeholders led to the development
of small networks and collaborations between centers
that promote the exchange of best-practice models and
improvement projects.
However, a number of limitations of the study should be
noted. First, we did not perform systematic psychometric
validations of the measures used. Most of the indicators
are based on existing measures previously validated and
reported the literature. However, some measures also stem
from the discussions and ratings by the consensus panels.
While these measures have high face validity in the stake-
holder group they may lack the presumed associations
with outcomes, which should be addressed by future
research [20]. Secondly, several factors might have con-
founded the improvements observed. As a starting point,
this is the first evaluation of the sector that was carried
out and it might be argued that centers started from a
rather low baseline level. The improvements observed
might thus reflect quality improvement actions that are
easy to implement. Another factor explaining the improve-
ments observed might be the three year time lag between
baseline and follow up assessment. This time lag is on the
one hand justified given the efforts to perform the assess-
ment, provide center-specific and sector-wide perfor-
mance feedback, implement quality improvement actions
and prepare the follow up evaluation. On the other hand,
this time lag also means that changes or evolutions in
delivery, organization, or regulatory measures of social
care might have influenced the results. Controlling for
these potential confounding factors; however, would be in
contradiction to our methodological approach which aims
at involving all sector stakeholders and policy makers in
addressing those quality problems that are beyond the
control of an individual center. In this sense, our approach
puts higher emphasis on working with the sector’s stake-
holders in addressing real life quality improvement actions
(ecological validity) than on reducing threats to linking
specific interventions to specific outcomes measures
(internal validity) [21]. This is in line with what Berwick
and quality improvement experts calls the ‘pragmatic
science’ approach which gives importance to the context
that shape the design and implementation of quality
improvement strategies, rather than assuming that a ‘best-
model’ exists that can be applied irrespective of contextual
characteristics [22,23]. While maintaining the main orien-
tations of our approach we plan for future evaluations to
allow the applications of multi-level statistical models,
which was not possible given the current algorithms for
data collection [24]. Such an approach would allow a
more in-depth analysis of the variations in improvements
between and within centers, accounting for characteristics
of users and organizational context.
Conclusions
In conclusion, we report on an evaluation and improve-
ment method for centers for attention and follow up of
drugs users in Catalonia, Spain, in which importance is
given to involve stakeholders in the development of per-
formance measures and in which assessments are per-
formed externally by independent evaluators. This method
is designed to involve and motivate a whole sector in a
given area. The results indicate that major improvements
between baseline and follow up evaluation using these per-
formance measure that are developed to ‘make sense’ for
those being evaluated and that use standards that users
themselves consider to be motivated and attainable. We
believe that the broad involvement of stakeholders and the
non-punishing nature of our approach to evaluation and
improvement are key factors that might explain the sub-
stantial improvements observed. Further research should
address how contextual issues shape the uptake and effec-
tiveness of quality improvement actions, and how such
quality improvements can be sustained.
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